COMP <GO>
CVRX vs XTNT // 10Y YIELD & FRED MACRO BETA
CVRx Inc. (NASDAQ) VS. Xtant Medical Holdings Inc. (NYSE) • 15-METRIC TALLY: CVRX 1
— XTNT 7
■ METRIC PARITY
LAST: $1.43 (+1.79%) • MKT CAP: $38.0M
macro-sensitivity
—
LAST: $0.29 (+1.54%) • MKT CAP: $40.7M
macro-sensitivity
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CVRX VS. XTNT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CVRX | XTNT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 85.30% | 62.90% | +22.40 | CVRX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 12.80% | -47.80 | XTNT | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 3.7x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 24.95% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | 5.40% | -65.40 | XTNT | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 0.00% | -60.00 | XTNT | /net-margins <GO> |
| Revenue Growth (YoY) | 10.40% | 14.20% | -3.80 | XTNT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.20 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 9/9 | -4.00 | XTNT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 31.9 | 34.9 | -3.06 | XTNT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $38.0M | $40.7M | -$2.8M | XTNT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CVRX REV | XTNT REV | CVRX GROSS % | XTNT GROSS % | CVRX FCF | XTNT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $56.7M | $133.9M | 85.3% | 62.9% | -$40.8M | $10.2M |
| FY 2024 | $51.3M | $117.3M | 83.8% | 58.2% | -$40.5M | -$16.0M |
| FY 2023 | $39.3M | $91.3M | — | — | -$39.0M | -$9.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CVRX // BETA —
XTNT // BETA —